Banner

Breast Cancer Diagnostics Global Market Report 2023 – By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies), By Cancer Type (BRCA Breast Cancer, ER and PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types), By Diagnostic Type (Ionizing Breast Imaging Technologies, Nonionizing Imaging Technologies), By End Users (Hospitals and Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : January 2023 | SKU CODE : r1392 | Delivery Time: 2-3 business days | Format :


Breast cancer is characterised by uncontrolled growth of cells in the breast, causing lumps. The breast cancer diagnostic devices are used to diagnose cancer that occurs in the breasts.

The main types of breast cancer diagnostics are imaging, biopsy, genomic tests, blood tests, and others. A biopsy is the process of removing a piece of tissue or a sample of cells from the body so that it can be tested in a laboratory. The technologies involved is fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), immunohistochemical (IHC), and other technologies. The cancer types involved are BRCA breast cancer, ER and PR breast cancer, her type 2-breast cancer, EGFR mutation test breast cancer, and others. The diagnostic types involved are ionising breast imaging technologies and non-ionizing imaging technologies. The end-users involved are hospitals and clinics, cancer research centers, diagnostic laboratories, and ambulatory surgical centers.

The breast cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides breast cancer diagnostics market statistics, including breast cancer diagnostics industry global market size, regional shares, competitors with a breast cancer diagnostics market share, detailed breast cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the breast cancer diagnostics industry. This breast cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global breast cancer diagnostics market grew from $4.06 billion in 2022 to $4.4 billion in 2023 at a compound annual growth rate (CAGR) of 8.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The breast cancer diagnostics market is expected to grow from $5.86 billion in 2027 at a CAGR of 7.4%.

The increasing incidence of breast cancer will require more equipment to diagnose, which will further increase the demand for the breast cancer diagnostics market. Breast cancer is the most common form of cancer, affecting 2.1 million women every year, and causing the largest number of deaths from cancer in women. The goal of the early diagnosis is to improve the percentage of breast cancers diagnosed at an initial point so that more successful care will be used and the risk of death from breast cancer can be reduced. According to the World Health Organization (WHO), around 2.3 million women were diagnosed with breast cancer and 685,000 people died of breast cancer in 2020. Therefore, the increasing incidence of breast cancer is expected to drive the growth of the breast cancer diagnostics market.

The high cost of diagnosis of breast cancer is a key factor that hinders the growth of the market for diagnostics of breast cancer. The cost of diagnosis for breast cancer typically rose with the initiation of the diagnostic stage of the disease. According to HealthMatch, in 2020, the total cost of breast cancer treatment ranged between $20,000 and $100,000. The diagnosis alone ranged between $151 and $751 in various regions. Therefore, the high-cost diagnosis of breast cancer makes the process a distant option and hinders the growth of the breast cancer diagnostics market.

Technological advancement is a key trend in the breast cancer diagnostics market. Several new techniques have been developed which could be used in the diagnosis and treatment of breast cancer. The 3D mammography, also known as breast tomosynthesis, takes photographs around the breast from various angles and translates them into a 3-D model. In September 2022, Niramai, an Indian Health-Tech company, launched an innovative solution called Thermalytix. It is a automated breast cancer screening and diagnostic tool which combines thermal imaging and AI.

In January 2021, Hologic, a US-based women’s health medtech company, acquired Somatex Medical for $64 million. The acquisition would support Hologic’s strategy to provide comprehensive solutions for breast health care. Somatex is a German-based provider of Breast cancer diagnostic services.

Major players in the breast cancer diagnostics market are Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., and C.R. Bard Inc.

North America was the largest region in the breast cancer diagnostics market in 2022. Asia-Pacific was the second largest region in the global breast cancer diagnostics market. The regions covered in the global breast cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the breast cancer diagnostics market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The breast cancer diagnostics market consists of sales of instruments such as analyzer, reagents and others that are used for the diagnosis of breast cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global breast cancer diagnostics market is segmented -

1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types

2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

3) By Cancer Type: BRCA Breast Cancer, ER & PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types

4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies

5) By End Users: Hospitals and Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

    Table Of Contents

    1. Executive Summary

    2. Breast Cancer Diagnostics Market Characteristics

    3. Breast Cancer Diagnostics Market Trends And Strategies

    4. Breast Cancer Diagnostics Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Breast Cancer Diagnostics Market

    4.2 Ukraine-Russia War Impact On Breast Cancer Diagnostics Market

    4.3 Impact Of High Inflation On Breast Cancer Diagnostics Market

    5. Breast Cancer Diagnostics Market Size And Growth

    5.1. Global Breast Cancer Diagnostics Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Breast Cancer Diagnostics Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Breast Cancer Diagnostics Market Segmentation

    6.1. Global Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Imaging

    Biopsy

    Genomic Tests

    Blood Tests

    Other Types

    6.2. Global Breast Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Fluorescent In Situ Hybridization (FISH)

    Comparative Genomic Hybridization (CGH)

    Immunohistochemical (IHC)

    Other Technologies

    6.3. Global Breast Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    BRCA Breast Cancer

    ER & PR Breast Cancer

    HER 2 Breast Cancer

    EGFR Mutation Test Breast Cancer

    Other Cancer Types

    6.4. Global Breast Cancer Diagnostics Market, Segmentation By Diagnostic Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Ionizing Breast Imaging Technologies

    Non-ionizing Imaging Technologies

    6.5. Global Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals and Clinics

    Cancer Research Centers

    Diagnostic Laboratories

    Ambulatory Surgical Centers

    7. Breast Cancer Diagnostics Market Regional And Country Analysis

    7.1. Global Breast Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Breast Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Breast Cancer Diagnostics Market

    8.1. Asia-Pacific Breast Cancer Diagnostics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Breast Cancer Diagnostics Market

    9.1. China Breast Cancer Diagnostics Market Overview

    9.2. China Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Breast Cancer Diagnostics Market

    10.1. India Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Breast Cancer Diagnostics Market

    11.1. Japan Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Breast Cancer Diagnostics Market

    12.1. Australia Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Breast Cancer Diagnostics Market

    13.1. Indonesia Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Breast Cancer Diagnostics Market

    14.1. South Korea Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Breast Cancer Diagnostics Market

    15.1. Western Europe Breast Cancer Diagnostics Market Overview

    15.2. Western Europe Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Breast Cancer Diagnostics Market

    16.1. UK Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Breast Cancer Diagnostics Market

    17.1. Germany Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Breast Cancer Diagnostics Market

    18.4. France Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Breast Cancer Diagnostics Market

    19.1. Eastern Europe Breast Cancer Diagnostics Market Overview

    19.2. Eastern Europe Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Breast Cancer Diagnostics Market

    20.1. Russia Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Breast Cancer Diagnostics Market

    21.1. North America Breast Cancer Diagnostics Market Overview

    21.2. North America Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Breast Cancer Diagnostics Market

    22.1. USA Breast Cancer Diagnostics Market Overview

    22.2. USA Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Breast Cancer Diagnostics Market

    23.1. South America Breast Cancer Diagnostics Market Overview

    23.2. South America Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Breast Cancer Diagnostics Market

    24.1. Brazil Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Breast Cancer Diagnostics Market

    25.1. Middle East Breast Cancer Diagnostics Market Overview

    25.2. Middle East Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Breast Cancer Diagnostics Market

    26.1. Africa Breast Cancer Diagnostics Market Overview

    26.2. Africa Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Breast Cancer Diagnostics Market Competitive Landscape And Company Profiles

    27.1. Breast Cancer Diagnostics Market Competitive Landscape

    27.2. Breast Cancer Diagnostics Market Company Profiles

    27.2.1. Abbott Laboratories

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Myriad Genetics Inc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Hologic Inc

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Koninklijke Philips N.V.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Fujifilm Holdings Corporation

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Breast Cancer Diagnostics Market

    29. Breast Cancer Diagnostics Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Breast Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Breast Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Breast Cancer Diagnostics Market, Segmentation By Diagnostic Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Breast Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Global Breast Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: Asia-Pacific, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: China, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: India, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Japan, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Australia, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: Indonesia, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: South Korea, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Western Europe, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: UK, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: Germany, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: France, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Eastern Europe, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: Russia, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: North America, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: USA, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: South America, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Brazil, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Middle East, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Africa, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 48: Abbott Laboratories Financial Performance
  • Table 49: Myriad Genetics Inc Financial Performance
  • Table 50: Hologic Inc Financial Performance
  • Table 51: Koninklijke Philips N.V. Financial Performance
  • Table 52: Fujifilm Holdings Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Breast Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Breast Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Breast Cancer Diagnostics Market, Segmentation By Diagnostic Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Breast Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Global Breast Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: Asia-Pacific, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: China, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: India, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Japan, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Australia, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: Indonesia, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: South Korea, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Western Europe, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: UK, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: Germany, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: France, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Eastern Europe, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: Russia, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: North America, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: USA, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: South America, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Brazil, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Middle East, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Breast Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Africa, Breast Cancer Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 48: Abbott Laboratories Financial Performance
  • Figure 49: Myriad Genetics Inc Financial Performance
  • Figure 50: Hologic Inc Financial Performance
  • Figure 51: Koninklijke Philips N.V. Financial Performance
  • Figure 52: Fujifilm Holdings Corporation Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report